From: Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease
NAFLD cases with early fibrosis | |||||||
miR-192 | miR-192 CT | miR-16 CT (normalize) | ΔCt | ΔΔCt | Mean fold change | p-value | Regulation |
28.81 ± 1.99 | 17.67 ± 2.8 | 11.1±2.59 | −1.66 ± 2.59 | 18.43 ± 47.8 | 0.017* | Upregulated | |
NAFLD cases with advanced fibrosis | |||||||
miR-192 CT | miR-16 CT (normalize) | Mean ΔCt | Mean ΔΔCt | Mean fold change | p-value | Regulation | |
28.67 ± 4.16 | 14.89 ± 2.06 | 13.78 ± 4.8 | 0.98 ± 4.8 | 5.36 ± 8.89 | 0.530 | Upregulated |